Furthermore, pharmacological GLUT1 inhibition with WZB117 reduced proliferation (Figure 5A, Suppl.Figure 9A) and XTT activity (Figure 5B, Suppl.Figure 9B) of human melanoma cells in vitro. The gene discussed is SLC2A1; the disease is melanoma.